- Home
- MESA vs CVKD Comparison
MESA vs CVKD Comparison
Compare MESA & CVKD Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- MESA
- CVKD
- Stock Information
- Founded
- MESA 1982
- CVKD 2022
- Country
- MESA United States
- CVKD United States
- Employees
- MESA N/A
- CVKD N/A
- Industry
- MESA Air Freight/Delivery Services
- CVKD Medicinal Chemicals and Botanical Products
- Sector
- MESA Consumer Discretionary
- CVKD Health Care
- Exchange
- MESA Nasdaq
- CVKD Nasdaq
- Market Cap
- MESA 29.1M
- CVKD 31.5M
- IPO Year
- MESA 2018
- CVKD 2023
- Fundamental
- Price
- MESA $1.17
- CVKD $16.88
- Analyst Decision
- MESA
- CVKD Strong Buy
- Analyst Count
- MESA 0
- CVKD 1
- Target Price
- MESA N/A
- CVKD $32.00
- AVG Volume (30 Days)
- MESA 3.2M
- CVKD 20.4K
- Earning Date
- MESA 06-17-2025
- CVKD 05-08-2025
- Dividend Yield
- MESA N/A
- CVKD N/A
- EPS Growth
- MESA N/A
- CVKD N/A
- EPS
- MESA N/A
- CVKD N/A
- Revenue
- MESA $475,518,000.00
- CVKD N/A
- Revenue This Year
- MESA $15.09
- CVKD N/A
- Revenue Next Year
- MESA $16.19
- CVKD N/A
- P/E Ratio
- MESA N/A
- CVKD N/A
- Revenue Growth
- MESA N/A
- CVKD N/A
- 52 Week Low
- MESA $0.68
- CVKD $5.70
- 52 Week High
- MESA $1.89
- CVKD $22.90
- Technical
- Relative Strength Index (RSI)
- MESA 63.25
- CVKD 50.50
- Support Level
- MESA $1.05
- CVKD $15.85
- Resistance Level
- MESA $1.13
- CVKD $17.33
- Average True Range (ATR)
- MESA 0.10
- CVKD 1.44
- MACD
- MESA 0.03
- CVKD 0.18
- Stochastic Oscillator
- MESA 89.09
- CVKD 72.23
About MESA Mesa Air Group Inc.
Mesa Air Group Inc is a regional air carrier providing scheduled passenger service. It provides scheduled passenger service to 86 cities in 36 states, the District of Columbia, Canada, Cuba, and Mexico as well as cargo services out of Cincinnati/Northern Kentucky International Airport. Flights are operated as American Eagle, United Express, or DHL Express flights to the terms of capacity purchase agreements with American and United and a flight services agreement with DHL. The business has a presence in domestic hubs and cities, including Dallas, Houston, Phoenix, and Washington-Dulles and other regions.
About CVKD Cadrenal Therapeutics Inc.
Cadrenal Therapeutics Inc is developing tecarfarin, its drug candidate, for unmet needs in anticoagulation therapy. Tecarfarin is a late-stage novel oral and reversible anticoagulant (blood thinner) designed to prevent heart attacks, strokes, and deaths due to blood clots in patients with rare cardiovascular conditions requiring chronic anticoagulation.